Impact of intravesical hyaluronic acid and chondroitin sulfate on bladder pain syndrome/interstitial cystitis

Int Urogynecol J. 2012 Sep;23(9):1193-9. doi: 10.1007/s00192-011-1546-5. Epub 2011 Sep 9.

Abstract

Introduction and hypothesis: Intravesical instillations of hyaluronic acid (HA) and chondroitin sulfate (CS) may lead to regeneration of the damaged glycosaminoglycan layer in interstitial cystitis/bladder pain syndrome (IC/BPS).

Methods: Twenty-two patients with IC/BPS received intravesical instillations (40 ml) of sodium HA 1.6% and CS 2.0% in 0.9% saline solution (IALURIL, IBSA) once weekly for 8 weeks, then once every 2 weeks for the next 6 months.

Results: The score for urgency was reduced from 6.5 to 3.6 (p = 0.0001), with a reduction in pain scores from an average of 5.6 to 3.2 (p = 0.0001). The average urine volume increased from 129.7 to 162 ml (p < 0.0001), with a reduction in the number of voids in 24 h, from 14 to 11.6 (p < 0.0001). The IC Symptom and Problem Index decreased from 25.7 to 20.3 (p < 0.0001), and the Pain Urgency Frequency score, from 18.7 to 12.8 (p < 0.0001).

Conclusion: The treatment appeared to be effective and well tolerated in IC/BPS in this initial experience.

Publication types

  • Clinical Trial

MeSH terms

  • Adjuvants, Immunologic / administration & dosage*
  • Administration, Intravesical
  • Adult
  • Anti-Inflammatory Agents / administration & dosage*
  • Chondroitin Sulfates / administration & dosage*
  • Cystitis, Interstitial / complications
  • Cystitis, Interstitial / drug therapy*
  • Female
  • Humans
  • Hyaluronic Acid / administration & dosage*
  • Lower Urinary Tract Symptoms / drug therapy
  • Lower Urinary Tract Symptoms / etiology
  • Middle Aged
  • Pain Measurement
  • Surveys and Questionnaires
  • Urination / drug effects
  • Urine
  • Young Adult

Substances

  • Adjuvants, Immunologic
  • Anti-Inflammatory Agents
  • Hyaluronic Acid
  • Chondroitin Sulfates